Evaluation of Cell-Mediated Immune Function Using the Cytotoxic T-Lymphocyte Assay
Evaluation of cell-mediated immunity (CMI) is a significant component in any assessment designed to predict the full range of potential immunotoxic risk underlying health risks. Among measures of CMI, the cytotoxic T-lymphocyte (CTL) response is recognized as perhaps the most relevant functional measure that reflects cell-mediated acquired immune defense against viral infections and cancer. The CTL response against T-dependent antigens requires the cooperation of at least three different major categories of immune cells. These include professional antigen-presenting cells (e.g., dendritic cells), CD4+ T helper lymphocytes, and CD8+ T effector lymphocytes. It is also among the few functional responses dependent on and, hence, capable of evaluating effective antigen presentation via both class I and class II molecules of the major histocompatibility complex (MHC). For this reason, the CTL assay is an excellent candidate for evaluation of potential immunotoxicity. This chapter provides an example of a mouse CTL assay against influenza virus that has been utilized for this purpose.
Key wordsCell-mediated immune function CMI Cytotoxic T lymphocyte CTL Influenza virus Natural infection Mouse
The authors thank Janice Dietert for her editorial suggestions. It is noted that R.R. Dietert previously served as a consultant in developmental immunotoxicology for Burleson Research Technologies, Inc.
- 2.Asherson CR, Stone SH (1962) Selective and specific inhibition of 24 hour skin reactions in the guinea pig. I. Immune deviation: description of the phenomenon and the effect of splenectomy. Immunology 9:205–217Google Scholar
- 13.Menasche G, Menager MM, Lefebvre JM, Deutsche E, Athman R, Lambert N, Mahlaoui N, Court M, Garin J, Fischer A, de Saint Basile G (2008) A newly identified isoform of Slp2a associates with Rab27a in cytotoxic T cells and participates to cytotoxic granule secretion. Blood 112:5052–5062CrossRefPubMedGoogle Scholar
- 27.Xu L, Xu W, Jiang Z, Zhang F, Chu Y, Xiong S (2009) Depletion of CD4(+)CD25(high) regulatory T cells from tumor infiltrating lymphocytes predominantly induces Th1 type immune response in vivo which inhibits tumor growth in adoptive immunotherapy. Cancer Biol Ther 8(1):66–72CrossRefPubMedGoogle Scholar
- 32.Ansen S, Butler MO, Berezovskaya A, Murray AP, Stevenson K, Nadler LM, Hirano N (2008) Dissociation of its opposing immunologic effects is critical for the optimization of antitumor CD8+ T-cell responses induced by interleukin 21. Clin Cancer Res 14:6125–6136CrossRefPubMedPubMedCentralGoogle Scholar
- 46.De Krey GK, Bauecher-Steppan L, Deyo JA, Smith B, Kerkvliet NI (1993) Polychlorinated biphenyl-induced immune suppression: castration, but not adrenalectomy or RU 38486 treatment, partially restores the suppressed cytotoxic T lymphocyte response to alloantigen. J Pharmacol Exp Ther 267:308–315PubMedGoogle Scholar
- 56.Dietert RR (2008) Influenza host resistance assay to assess developmental immunotoxicity (DIT). Int. J Immunotoxicol 27(6):416Google Scholar
- 58.Burleson GR, Burleson FG (2008) Host resistance models to evaluate immunotoxicity. In: Herzyk D, Bussiere J (eds) Immunotoxicology strategies for pharmaceutical safety assessment. Wiley, Hoboken, NJGoogle Scholar